{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,3]],"date-time":"2024-11-03T04:10:43Z","timestamp":1730607043769,"version":"3.28.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,2]]},"DOI":"10.7759\/cureus.72897","type":"journal-article","created":{"date-parts":[[2024,11,2]],"date-time":"2024-11-02T20:16:07Z","timestamp":1730578567000},"source":"Crossref","is-referenced-by-count":0,"title":["Genetic Testing and Analysis in Breast Cancer Patients in Greece"],"prefix":"10.7759","author":[{"given":"Ioannis","family":"Rellias","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Drakoulis","family":"Yannoukakos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florentia","family":"Fostira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paraskevi","family":"Apostolou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Pampanos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitrios","family":"Loutradis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Daskalakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Constantine","family":"Dimitrakakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray F","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024, 74:229-63. 10.3322\/caac.21834","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-021-08310-9","article-title":"Germline mutations in a clinic-based series of pregnancy associated breast cancer patients","volume":"21","author":"Zografos E","year":"2021","unstructured":"Zografos E, Korakiti AM, Andrikopoulou A, et al.. Germline mutations in a clinic-based series of pregnancy associated breast cancer patients. BMC Cancer. 2021, 21:572. 10.1186\/s12885-021-08310-9","journal-title":"BMC Cancer"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2021.07.039","article-title":"The European cancer burden in 2020: Incidence and mortality estimates for 40 countries and 25 major cancers","volume":"157","author":"Dyba T","year":"2021","unstructured":"Dyba T, Randi G, Bray F, et al.. The European cancer burden in 2020: Incidence and mortality estimates for 40 countries and 25 major cancers. Eur J Cancer. 2021, 157:308-47. 10.1016\/j.ejca.2021.07.039","journal-title":"Eur J Cancer"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1913948","article-title":"Breast cancer risk genes \u2014 association analysis in more than 113,000 women","volume":"384","author":"Dorling L","year":"2021","unstructured":"Dorling L, Carvalho S, Allen J, et al.. Breast cancer risk genes \u2014 association analysis in more than 113,000 women. N Engl J Med. 2021, 384:428-39. 10.1056\/NEJMoa1913948","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2005936","article-title":"A population-based study of genes previously implicated in breast cancer","volume":"384","author":"Hu C","year":"2021","unstructured":"Hu C, Hart SN, Gnanaolivu R, et al.. A population-based study of genes previously implicated in breast cancer. N Engl J Med. 2021, 384:440-51. 10.1056\/NEJMoa2005936","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.34365","article-title":"Breast cancer incidence among women with a family history of breast cancer by relative's age at diagnosis","volume":"128","author":"Durham DD","year":"2022","unstructured":"Durham DD, Abraham LA, Roberts MC, Khan CP, Smith RA, Kerlikowske K, Miglioretti DL. Breast cancer incidence among women with a family history of breast cancer by relative's age at diagnosis. Cancer. 2022, 128:4232-40. 10.1002\/cncr.34365","journal-title":"Cancer"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2022.107062","article-title":"Prevalence of Americans reporting a family history of cancer indicative of increased cancer risk: estimates from the 2015 National Health Interview Survey","volume":"159","author":"Kumerow MT","year":"2022","unstructured":"Kumerow MT, Rodriguez JL, Dai S, Kolor K, Rotunno M, Peipins LA. Prevalence of Americans reporting a family history of cancer indicative of increased cancer risk: estimates from the 2015 National Health Interview Survey. Prev Med. 2022, 159:107062. 10.1016\/j.ypmed.2022.107062","journal-title":"Prev Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.02225","article-title":"Germline testing in patients with breast cancer: ASCO-Society of Surgical Oncology Guideline","volume":"42","author":"Bedrosian I","year":"2024","unstructured":"Bedrosian I, Somerfield MR, Achatz MI, et al.. Germline testing in patients with breast cancer: ASCO-Society of Surgical Oncology Guideline. J Clin Oncol. 2024, 42:584-604. 10.1200\/JCO.23.02225","journal-title":"J Clin Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-019-07549-8","article-title":"Consensus guidelines on genetic` testing for hereditary breast cancer from the American Society of Breast Surgeons","volume":"26","author":"Manahan ER","year":"2019","unstructured":"Manahan ER, Kuerer HM, Sebastian M, et al.. Consensus guidelines on genetic` testing for hereditary breast cancer from the American Society of Breast Surgeons. Ann Surg Oncol. 2019, 26:3025-31. 10.1245\/s10434-019-07549-8","journal-title":"Ann Surg Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdz173","article-title":"Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"30(8)","author":"Cardoso F","year":"2019","unstructured":"Cardoso F, Kyriakides S, Ohno S, et al.. Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2019, 30(8):1194-220. 10.1093\/annonc\/mdz173","journal-title":"Ann Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/cge.12274","article-title":"High prevalence of BRCA1 founder mutations in Greek breast\/ovarian families","volume":"85","author":"Konstantopoulou I","year":"2014","unstructured":"Konstantopoulou I, Tsitlaidou M, Fostira F, et al.. High prevalence of BRCA1 founder mutations in Greek breast\/ovarian families. Clin Genet. 2014, 85:36-42. 10.1111\/cge.12274","journal-title":"Clin Genet"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6605115","article-title":"Contribution of BRCA1 germ-line mutations to breast cancer in Greece: a hospital-based study of 987 unselected breast cancer cases","volume":"101","author":"Armaou S","year":"2009","unstructured":"Armaou S, Pertesi M, Fostira F, et al.. Contribution of BRCA1 germ-line mutations to breast cancer in Greece: a hospital-based study of 987 unselected breast cancer cases. Br J Cancer. 2009, 101:32-7. 10.1038\/sj.bjc.6605115","journal-title":"Br J Cancer"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/cge.12824","article-title":"Haplotype analysis reveals that the recurrent BRCA1 deletion of exons 23 and 24 is a Greek founder mutation","volume":"91","author":"Apostolou P","year":"2017","unstructured":"Apostolou P, Pertesi M, Aleporou-Marinou V, et al.. Haplotype analysis reveals that the recurrent BRCA1 deletion of exons 23 and 24 is a Greek founder mutation. Clin Genet. 2017, 91:482-7. 10.1111\/cge.12824","journal-title":"Clin Genet"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-012-2021-9","article-title":"Prevalence of BRCA1 mutations among 403 women with triple-negative breast cancer: implications for genetic screening selection criteria: a Hellenic Cooperative Oncology Group Study","volume":"134","author":"Fostira F","year":"2012","unstructured":"Fostira F, Tsitlaidou M, Papadimitriou C, et al.. Prevalence of BRCA1 mutations among 403 women with triple-negative breast cancer: implications for genetic screening selection criteria: a Hellenic Cooperative Oncology Group Study. Breast Cancer Res Treat. 2012, 134:353-62. 10.1007\/s10549-012-2021-9","journal-title":"Breast Cancer Res Treat"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1136\/jmedgenet-2019-106189","article-title":"One in three highly selected Greek patients with breast cancer carries a loss-of-function variant in a cancer susceptibility gene","volume":"57","author":"Fostira F","year":"2020","unstructured":"Fostira F, Kostantopoulou I, Apostolou P, et al.. One in three highly selected Greek patients with breast cancer carries a loss-of-function variant in a cancer susceptibility gene. J Med Genet. 2020, 57:53-61. 10.1136\/jmedgenet-2019-106189","journal-title":"J Med Genet"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards S","year":"2015","unstructured":"Richards S, Aziz N, Bale S, et al.. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015, 17:405-24. 10.1038\/gim.2015.30","journal-title":"Genet Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-018-6486-6","article-title":"Eighth Edition of the AJCC Cancer Staging Manual: Breast Cancer","volume":"25","author":"Giuliano AE","year":"2018","unstructured":"Giuliano AE, Edge SB, Hortobagyi GN. Eighth Edition of the AJCC Cancer Staging Manual: Breast Cancer. Ann Surg Oncol. 2018, 25:1783-5. 10.1245\/s10434-018-6486-6","journal-title":"Ann Surg Oncol"},{"key":"ref18","unstructured":"NCCN guidelines version 1.2025 . (2024). Accessed. September 11, 2024: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/breast_risk.pdf."},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2009.09.007","article-title":"Structure and activation mechanism of the CHK2 DNA damage checkpoint kinase","volume":"35","author":"Cai Z","year":"2009","unstructured":"Cai Z, Chehab NH, Pavletich NP. Structure and activation mechanism of the CHK2 DNA damage checkpoint kinase. Mol Cell. 2009, 35:818-29. 10.1016\/j.molcel.2009.09.007","journal-title":"Mol Cell"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3390\/cells9122675","article-title":"CHEK2 germline variants in cancer predisposition: stalemate rather than checkmate","volume":"9","author":"Stolarova L","year":"2020","unstructured":"Stolarova L, Kleiblova P, Janatova M, Soukupova J, Zemankova P, Macurek L, Kleibl Z. CHEK2 germline variants in cancer predisposition: stalemate rather than checkmate. Cells. 2020, 9:10.3390\/cells9122675","journal-title":"Cells"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2016.147","article-title":"Genetic modifiers of CHEK2*1100delC-associated breast cancer risk","volume":"19","author":"Muranen TA","year":"2017","unstructured":"Muranen TA, Greco D, Blomqvist C, et al.. Genetic modifiers of CHEK2*1100delC-associated breast cancer risk. Genet Med. 2017, 19:599-603. 10.1038\/gim.2016.147","journal-title":"Genet Med"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.cancergen.2015.02.006","article-title":"CHEK2 c.1100delC allele is rarely identified in Greek breast cancer cases","volume":"208","author":"Apostolou P","year":"2015","unstructured":"Apostolou P, Fostira F, Papamentzelopoulou M, et al.. CHEK2 c.1100delC allele is rarely identified in Greek breast cancer cases. Cancer Genet. 2015, 208:129-34. 10.1016\/j.cancergen.2015.02.006","journal-title":"Cancer Genet"},{"key":"ref23","unstructured":"ClinVar. genomic variation as it relates to human health. Accessed: October 31, 2024: https:\/\/www.ncbi.nlm.nih.gov\/clinvar\/variation\/142524\/."},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.30498","article-title":"A study of over 35,000 women with breast cancer tested with a 25-gene panel of hereditary cancer genes","volume":"123","author":"Buys SS","year":"2017","unstructured":"Buys SS, Sandbach JF, Gammon A, et al.. A study of over 35,000 women with breast cancer tested with a 25-gene panel of hereditary cancer genes. Cancer. 2017, 123:1721-30. 10.1002\/cncr.30498","journal-title":"Cancer"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2014.0128","article-title":"Gene panel testing for inherited cancer risk","volume":"12","author":"Hall MJ","year":"2014","unstructured":"Hall MJ, Forman AD, Pilarski R, Wiesner G, Giri VN. Gene panel testing for inherited cancer risk. J Natl Compr Canc Netw. 2014, 12:1339-46. 10.6004\/jnccn.2014.0128","journal-title":"J Natl Compr Canc Netw"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv1222","article-title":"ClinVar: public archive of interpretations of clinically relevant variants","volume":"44","author":"Landrum MJ","year":"2016","unstructured":"Landrum MJ, Lee JM, Benson M, et al.. ClinVar: public archive of interpretations of clinically relevant variants. Nucleic Acids Res. 2016, 44:D862-8. 10.1093\/nar\/gkv1222","journal-title":"Nucleic Acids Res"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/305869-genetic-testing-and-analysis-in-breast-cancer-patients-in-greece","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,2]],"date-time":"2024-11-02T20:16:09Z","timestamp":1730578569000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/305869-genetic-testing-and-analysis-in-breast-cancer-patients-in-greece"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,2]]},"references-count":26,"URL":"https:\/\/doi.org\/10.7759\/cureus.72897","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11,2]]}}}